Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Biomedicine, College of Public Health, Medical and Veterinary Sciences, James Cook University, Douglas, Queensland, Australia.
Clin Exp Immunol. 2022 Dec 15;210(2):163-174. doi: 10.1093/cei/uxac082.
Natural killer (NK) cells are important anti-viral effector cells. The function and phenotype of the NK cells that constitute an individual's NK cell repertoire can be influenced by ongoing or previous viral infections. Indeed, infection with human cytomegalovirus (HCMV) drives the expansion of a highly differentiated NK cell population characterized by expression of CD57 and the activating NKG2C receptor. This NK cell population has also been noted to occur in HIV-1-infected individuals. We evaluated the NK cells of HIV-1-infected and HIV-1-uninfected individuals to determine the relative frequency of highly differentiated CD57+NKG2C+ NK cells and characterize these cells for their receptor expression and responsiveness to diverse stimuli. Highly differentiated CD57+NKG2C+ NK cells occurred at higher frequencies in HCMV-infected donors relative to HCMV-uninfected donors and were dramatically expanded in HIV-1/HCMV co-infected donors. The expanded CD57+NKG2C+ NK cell population in HIV-1-infected donors remained stable following antiretroviral therapy. CD57+NKG2C+ NK cells derived from HIV-1-infected individuals were robustly activated by antibody-dependent stimuli that contained anti-HIV-1 antibodies or therapeutic anti-CD20 antibody, and these NK cells mediated cytolysis through NKG2C. Lastly, CD57+NKG2C+ NK cells from HIV-1-infected donors were characterized by reduced expression of the inhibitory NKG2A receptor. The abundance of highly functional CD57+NKG2C+ NK cells in HIV-1-infected individuals raises the possibility that these NK cells could play a role in HIV-1 pathogenesis or serve as effector cells for therapeutic/cure strategies.
自然杀伤 (NK) 细胞是重要的抗病毒效应细胞。个体 NK 细胞库中 NK 细胞的功能和表型可受到持续或先前病毒感染的影响。事实上,人类巨细胞病毒 (HCMV) 感染会驱动高度分化的 NK 细胞群的扩增,其特征在于表达 CD57 和激活型 NKG2C 受体。在 HIV-1 感染个体中也观察到这种 NK 细胞群。我们评估了 HIV-1 感染和未感染个体的 NK 细胞,以确定高度分化的 CD57+NKG2C+ NK 细胞的相对频率,并对这些细胞进行受体表达和对各种刺激的反应性特征分析。与 HCMV 未感染供体相比,HCMV 感染供体中高度分化的 CD57+NKG2C+ NK 细胞的频率更高,并且在 HIV-1/HCMV 共感染供体中显著扩增。在接受抗逆转录病毒治疗后,HIV-1 感染供体中扩增的 CD57+NKG2C+ NK 细胞群体保持稳定。来自 HIV-1 感染个体的 CD57+NKG2C+ NK 细胞可被包含抗 HIV-1 抗体或治疗性抗 CD20 抗体的抗体依赖性刺激物强烈激活,并且这些 NK 细胞通过 NKG2C 介导细胞溶解。最后,来自 HIV-1 感染供体的 CD57+NKG2C+ NK 细胞的特征是抑制性 NKG2A 受体的表达减少。HIV-1 感染个体中高度功能性 CD57+NKG2C+ NK 细胞的丰富度提出了这样一种可能性,即这些 NK 细胞可能在 HIV-1 发病机制中发挥作用,或者作为治疗/治愈策略的效应细胞。